Precursor Lymphoid Neoplasm — Trials

Precursor Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 567
Recruiting: 344
Ph III recruiting: 27
Growth YoY: −11.9%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (286)

clinicaltrialsPublishedShowing 1–38 of 38 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06703216	Pre-emptive Anakinra for Cytokine Event Reduction(PACER)	withdrawn	Phase 1 / Phase 2	0	Kevin McNerneyOTHER	1	Aug 13, 2026	clinicaltrials
NCT07585734	Clinical Trial of CD38 Monoclonal Antibody Combined With Chemotherapy for T-Cell Acute Lymphoblastic Leukemia	withdrawn	Phase 1 / Phase 2	0	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	0	May 14, 2026